AR110106A1 - IMMUNOGLOBULINS AND USES OF THESE - Google Patents
IMMUNOGLOBULINS AND USES OF THESEInfo
- Publication number
- AR110106A1 AR110106A1 ARP170102981A ARP170102981A AR110106A1 AR 110106 A1 AR110106 A1 AR 110106A1 AR P170102981 A ARP170102981 A AR P170102981A AR P170102981 A ARP170102981 A AR P170102981A AR 110106 A1 AR110106 A1 AR 110106A1
- Authority
- AR
- Argentina
- Prior art keywords
- immunoglobulins
- therapeutic
- couple
- refers
- life
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente divulgación se refiere a una plataforma de anticuerpo monoclonal diseñada para acoplarse a péptidos terapéuticos para aumentar el periodo de semidesintegración del péptido terapéutico en un sujeto. Se refiere, además, a composiciones farmacéuticas y a métodos para su uso.The present disclosure relates to a monoclonal antibody platform designed to couple to therapeutic peptides to increase the half-life of the therapeutic peptide in a subject. It also refers to pharmaceutical compositions and methods for their use.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662413586P | 2016-10-27 | 2016-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR110106A1 true AR110106A1 (en) | 2019-02-27 |
Family
ID=65351710
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102979A AR109895A1 (en) | 2016-10-27 | 2017-10-26 | CYCLICAL COMPOUNDS OF TYPOSINE TYPEOSEPHYPE PEPTIDE AS NEUROPEPTIDE MODULATORS AND RECEPTORS |
| ARP170102980A AR109979A1 (en) | 2016-10-27 | 2017-10-26 | CYCLICAL COMPOUNDS PEPTIDE TYPEOSINE-TYROSINE COUPLED TO ANTIBODIES AS MODULATORS OF NEUROPEPTIDE RECEPTORS AND |
| ARP170102981A AR110106A1 (en) | 2016-10-27 | 2017-10-26 | IMMUNOGLOBULINS AND USES OF THESE |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102979A AR109895A1 (en) | 2016-10-27 | 2017-10-26 | CYCLICAL COMPOUNDS OF TYPOSINE TYPEOSEPHYPE PEPTIDE AS NEUROPEPTIDE MODULATORS AND RECEPTORS |
| ARP170102980A AR109979A1 (en) | 2016-10-27 | 2017-10-26 | CYCLICAL COMPOUNDS PEPTIDE TYPEOSINE-TYROSINE COUPLED TO ANTIBODIES AS MODULATORS OF NEUROPEPTIDE RECEPTORS AND |
Country Status (1)
| Country | Link |
|---|---|
| AR (3) | AR109895A1 (en) |
-
2017
- 2017-10-26 AR ARP170102979A patent/AR109895A1/en unknown
- 2017-10-26 AR ARP170102980A patent/AR109979A1/en unknown
- 2017-10-26 AR ARP170102981A patent/AR110106A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR109979A1 (en) | 2019-02-13 |
| AR109895A1 (en) | 2019-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY37456A (en) | IMMUNOGLOBULINAS AND ITS USES | |
| CO2018010458A2 (en) | Anti-tim-3 antibodies and compositions | |
| ECSP18082207A (en) | NEOANTIGES AND METHODS OF USE | |
| DOP2017000031A (en) | ANTI-CTLA4 MONOCLONAL ANTIBODY OR ITS ANTIGEN BINDING FRAGMENT, A PHARMACEUTICAL COMPOSITION AND USE | |
| CL2017001610A1 (en) | Human antibodies to influenza hemagglutinin | |
| CL2017003261A1 (en) | Factor xi antibodies and methods of use | |
| CO2018003477A2 (en) | Anti-PD1 antibodies and methods of use | |
| ECSP18096095A (en) | ALPHA-SINUCLEIN ANTIBODIES AND USES OF THEM | |
| RS66372B1 (en) | ANTI-PD1 MONOCLONAL ANTIBODY, ITS PHARMACEUTICAL COMPOSITION AND ITS USE | |
| EA201791093A1 (en) | ANTIBODIES TO CD47, METHODS AND USE | |
| BR112017006178A2 (en) | fc region, antibodies, pharmaceutical formulation and uses of antibodies | |
| MY185802A (en) | Antibody formulation | |
| EA201790569A1 (en) | ANTIBODIES AND IMMUNOCONJUGATES AGAINST CLL-1 | |
| UY36021A (en) | FC MULTIMÈRIC PROTEINS | |
| EA201790239A1 (en) | MOLECULE CARRIER FOR ANTIGENS | |
| BR112019001233A2 (en) | pharmaceutical formulation and use thereof | |
| CL2016001753A1 (en) | Humanized monoclonal antibody that specifically binds to netrin-1, pharmaceutical compositions and uses of the antibody for cancer treatment | |
| CU20170012A7 (en) | ANTIBODIES ANTI PROTEIN SIMILAR TO ANGIOPOYETINA 4 | |
| PE20180691A1 (en) | VARIANTS OF IL-37 | |
| MX2018014716A (en) | Anti-tnfrsf25 antibodies. | |
| AR101671A1 (en) | ANTIBODIES ANTI PROTEIN SIMILAR TO ANGIOPOYETINA-4 (ANGPTL4) AND METHODS OF USE | |
| EA201990768A1 (en) | OPTIMIZED SYNTHETIC CONSENSUS IMMUNOGENIC COMPOSITIONS AIMED AT FIBROBLAST ACTIVATION PROTEIN | |
| AR110106A1 (en) | IMMUNOGLOBULINS AND USES OF THESE | |
| EA201991022A1 (en) | IMMUNOGLOBULINS AND THEIR APPLICATION | |
| AR107223A1 (en) | DIRECTED ANTIBODIES AGAINST UPK1B AND METHODS FOR USE |